Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet
Anna Mc Laughlin, Dr. rer. nat.
Consultant
Pharmetheus, Ireland
Poster(s):
(M-074) Exposure-efficacy analysis of datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate, in patients with advanced non-small cell lung cancer
Monday, November 11, 2024
7:00 AM – 5:00 PM
MST
Email Anna
